Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study (Q38670952)
scientific article published on 04 December 2015
Language:
(P31) (Q13442814)
(P50) (Q43008289)
(Q57724597)
(Q45514575)
(Q43704049)
(Q87777731)
(Q44434942)
(Q90928845)
(P304) 770-778
(P407) (Q1860)
(P433) 10020
(P478) 387
(P577) Friday, December 4, 2015
(P921) (Q5984881)
(P1433) (Q939416)
(P1476) "Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study" (language: en)
(P2093) Martin Dreyling
Rodrigo Santucci Silva
Chiara Rusconi
Fritz Offner
Dolores Caballero
Georg Hess
John Bothos
Jenna D Goldberg
Christopher Enny
Shana Traina
Sriram Balasubramanian
Nibedita Bandyopadhyay
Steven Sun
Jessica Vermeulen
Aleksandra Rizo
Simon Rule
(P2860) (Q84320340)
(Q22306235)
(Q57217007)
(Q38123021)
(Q85004110)
(Q54521749)
(Q37997075)
(Q39107651)
(Q34249777)
(Q34026194)
(Q24633214)
(Q34029869)
(Q30371806)
(Q30279207)
(Q35848973)
(Q33366976)
(Q33379949)
(Q33385283)
(Q47582438)
(Q29619399)
(Q28254924)
(Q33372761)
(Q30358639)
other details
description scientific article published on 04 December 2015

External Links